JC

Jay Cui

Principal at Abingworth

Menlo Park, California

Overview 

Jay Cui is currently a Principal at Abingworth in Menlo Park, California, with a background in organic synthesis and molecular biology. Notable highlights of his career include serving as a Director at AbbVie Ventures and holding a Ph.D. from the University of Chicago, along with an MBA with Honors from The University of Chicago Booth School of Business.

Work Experience 

A

Abingworth

  • Principal

    2021 - Current

AT

Accent Therapeutics, Inc.

  • Board Observer

    2021 - 2021

Accent Therapeutics is a biopharmaceutical company.

Raised $178,000,000.00 from Bristol-Myers Squibb, Atlas Venture, NS Investment, Mirae Asset Venture Investment, EcoR1 Capital, Mirae Asset Capital, The Mark Foundation for Cancer Research, Droia Ventures, The Column Group and Mirae Asset Capital Life Science.

accenttx.com
CB

Caribou Biosciences

  • Board Observer

    2021 - 2021

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Raised $317,699,904.00 from Pfizer.

cariboubio.com
A

AbbVie

  • Director, AbbVie Ventures

    2017 - 2021

    AbbVie Ventures is the venture capital arm of AbbVie and is dedicated to making equity investments in emerging biotech companies in oncology, immunology, and neurodegenerative diseases.

AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.

Raised $15,000,249,999.00.

abbvie.com

Disarm Therapeutics

  • Board Observer

    2019 - 2020

ZA

ZS Associates

  • Business Consultant

    2015 - 2017

    Management consultant focusing on biopharma, medical device, and healthcare service industries

CA

Campbell Alliance

  • Management Consultant

    2015 - 2015

    Management consultant in the corporate development practice; advised clients in the biotechnology, medical device and animal health industries on multiple commercial and corporate strategy projects.

Chicago Tri-Institutional Center for Chemical Methods and Library Development

  • Library Development Core Leader

    2010 - 2014

    • Planned and oversaw setup of a $2M research laboratory funded by a National Institutes of Health P50 grant; Built multifunctional research team and established standard operating protocols • Led team creating 5,000+ structurally diverse, high purity chemicals for screening; established 20+ collaborative projects nationwide and with NIH MLPCN network, leading to drug leads against breast cancer, diabetes and neurodegenerative diseases • Guest lecturer for UChicago Ph.D. level course: High-Thoughtput Methods in Organic Chemistry

TP

Takeda Pharmaceuticals

  • Corporate Portfolio Management

    2014 - 2014

    Internship at the Global Portfolio Management Team within the Chief Medical and Scientific Office (CMSO)

Education 

Articles About Jay

Relevant Websites